In Brief: Allergan
This article was originally published in The Rose Sheet
Executive Summary
Allergan: Confirms that it is in discussions regarding the "potential acquisition" of Herald Pharmacal, a Richmond, VA-based manufacturer and marketer of dermatological products. In a July 25 release, the company also said the Federal Trade Commission has granted early termination of the 60-day Hart-Scott-Rodino waiting period in connection with the possible merger. Herald's products are marketed primarily under the M.D. brand, sold through dermatologists and salons, and the Aqua Glycolic brand of glycolic acid-based products, sold through drug stores. The Allergan Herbert skin care division had sales of $37.3 mil. in 1994...